Page last updated: 2024-08-17

lysine and DDD MPGNII

lysine has been researched along with DDD MPGNII in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gilkeson, GS; Hofbauer, AF; Njoku, C; Oates, JC; Ruiz, P; Self, SE1
Heinen, S; Hoppe, B; Józsi, M; Kirschfink, M; Licht, C; Löschmann, I; Perkins, SJ; Saunders, RE; Skerka, C; Waldherr, R; Zipfel, PF1

Other Studies

2 other study(ies) available for lysine and DDD MPGNII

ArticleYear
Inducible nitric oxide synthase inhibitor SD-3651 reduces proteinuria in MRL/lpr mice deficient in the NOS2 gene.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2008, Volume: 56, Issue:7

    Topics: Animals; Antibodies, Antinuclear; Disease Models, Animal; Enzyme Inhibitors; Female; Glomerulonephritis, Membranoproliferative; Lupus Nephritis; Lysine; Male; Mice; Mice, Inbred C57BL; Mice, Inbred MRL lpr; Mice, Knockout; Nitric Oxide Synthase Type II; Proteinuria

2008
Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II).
    Kidney international, 2006, Volume: 70, Issue:1

    Topics: Amino Acid Sequence; Child; Complement C3 Nephritic Factor; Complement Factor H; Complement Pathway, Alternative; Consanguinity; Female; Glomerulonephritis, Membranoproliferative; Humans; Lysine; Molecular Sequence Data; Pedigree; Plasma; Protein Structure, Tertiary; Sequence Deletion

2006